Limited post hoc longitudinal studies have identified serum proteins as potential biomarkers for AATD progression, such as metalloprotease-9, desmosine, CRP, adipocyte fatty-acid-binding protein, and tissue plasminogen activator [26,27,28]. The gene discussed is CRP; the disease is alpha 1-antitrypsin deficiency.